Holen Sie sich die Stockscreener-App
115.15
3.44%
-4.10
Handel nachbörslich:
115.15
Schlusskurs vom Vortag:
$119.25
Offen:
$119.91
24-Stunden-Volumen:
440.20K
Relative Volume:
1.04
Marktkapitalisierung:
$1.92B
Einnahmen:
$5.82B
Nettoeinkommen (Verlust:
$-373.54M
KGV:
-5.1073
EPS:
-22.546
Netto-Cashflow:
$-87.01M
1W Leistung:
+1.80%
1M Leistung:
+24.78%
6M Leistung:
+524.29%
1J Leistung:
+99.39%
1-Tages-Spanne:
$113.12
$125.71
1-Wochen-Bereich:
$93.01
$125.71
52-Wochen-Spanne:
$7.48
$125.71
Agilon Health Inc Stock (AGL) Company Profile
Firmenname
Agilon Health Inc
Sektor
Branche
Telefon
562-256-3800
Adresse
440 POLARIS PARKWAY, WESTERVILLE
Compare AGL vs HCA, THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AGL
Agilon Health Inc
|
115.15 | 1.99B | 5.82B | -373.54M | -87.01M | -22.55 |
HCA
Hca Healthcare Inc
|
392.33 | 86.89B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
187.17 | 16.28B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
219.70 | 13.93B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
22.70 | 12.48B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
100.90 | 10.05B | 6.07B | 793.80M | 464.40M | 5.9914 |
Agilon Health Inc Stock (AGL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-20 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2025-08-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-25 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-04-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-10 | Hochstufung | Citigroup | Sell → Neutral |
| 2025-01-10 | Eingeleitet | Needham | Hold |
| 2024-12-16 | Eingeleitet | Macquarie | Neutral |
| 2024-12-11 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-11-11 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-11-08 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-10-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-10-02 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-04-22 | Eingeleitet | Citigroup | Neutral |
| 2024-03-06 | Eingeleitet | Barclays | Underweight |
| 2024-02-26 | Herabstufung | Jefferies | Buy → Hold |
| 2024-02-26 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2024-01-08 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-01-08 | Herabstufung | Stifel | Buy → Hold |
| 2024-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-01-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-01-05 | Herabstufung | Truist | Buy → Hold |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-11-21 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-10-20 | Eingeleitet | The Benchmark Company | Buy |
| 2023-06-13 | Eingeleitet | Evercore ISI | In-line |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-09-14 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-09-12 | Eingeleitet | Goldman | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-06-24 | Eingeleitet | BTIG Research | Neutral |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2021-10-20 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-05-11 | Eingeleitet | William Blair | Outperform |
| 2021-05-10 | Eingeleitet | BofA Securities | Buy |
| 2021-05-10 | Eingeleitet | Deutsche Bank | Buy |
| 2021-05-10 | Eingeleitet | Goldman | Buy |
| 2021-05-10 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-10 | Eingeleitet | Truist | Buy |
| 2021-05-10 | Eingeleitet | Wells Fargo | Overweight |
| 2021-05-10 | Eingeleitet | Wolfe Research | Outperform |
Alle ansehen
Agilon Health Inc Aktie (AGL) Neueste Nachrichten
Price to sales forward of agilon health, inc. – NYSE:AGL - TradingView
3 Reasons AGL is Risky and 1 Stock to Buy Instead - Yahoo! Finance Canada
agilon health, inc. (AGL) Investigation: Bronstein, Gewirtz & Gro - The National Law Review
Enterprise value to EBITDA forward of agilon health, inc. – NYSE:AGL - TradingView
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
AGL Stock Jumps As agilon Health Ramps Market Outreach - timothysykes.com
Enterprise value to EBITDA forward of agilon health, inc. – BOATS:AGL - TradingView
Is the options market predicting a spike in Agilon Health stock? - MSN
AGL Jumps As agilon health Steps Up Outreach To Wall Street - StocksToTrade
AGL Stock Jumps As Traders Weigh Insider Moves And Conference Push - timothysykes.com
AGL Stock Climbs As agilon health Steps Up Outreach - StocksToTrade
AGL Jumps As agilon health Steps Up Conference Push - timothysykes.com
AGL Stock Rockets As Traders Focus On Conference Catalyst - StocksToTrade
Enterprise value to revenue forward of agilon health, inc. – NYSE:AGL - TradingView
Enterprise value to revenue forward of agilon health, inc. – BOATS:AGL - TradingView
Agilon Health (AGL) Is Up 0.79% in One Week: What You Should Know - Yahoo Finance
Why Fast-paced Mover Agilon (AGL) Is a Great Choice for Value Investors - Yahoo Finance
Enterprise value to EBIT forward of agilon health, inc. – BOATS:AGL - TradingView
1 Small-Cap Stock on Our Watchlist and 2 We Question - The Globe and Mail
Price to earnings forward of agilon health, inc. – BOATS:AGL - TradingView
agilon health inc Actuals & Estimates (NYSE:AGL) - TradingView
AGL Forecast — Price Target — Prediction for 2027 - TradingView
agilon health inc (AGL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Citizens reiterates agilon health stock rating ahead of forum By Investing.com - Investing.com Nigeria
Citizens reiterates agilon health stock rating ahead of forum - Investing.com
agilon health inc (AGL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
agilon health: Q1 Inflection And A New CEO Set Up A Multi-Year Rerating - Seeking Alpha
Is the Options Market Predicting a Spike in agilon health Stock? - Zacks Investment Research
Agilon Health stock hits 52-week high at 118.47 USD By Investing.com - Investing.com Nigeria
Agilon Health stock hits 52-week high at 118.47 USD - Investing.com
Barclays Upgrades Agilon Health (AGL) - Insider Monkey
agilon health inc (AGL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Agilon health, inc.(NYSE: AGL) added to S&P Health Care Services Select Industry Index - marketscreener.com
agilon health inc (AGL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AGL Technical Analysis & Stock Price Forecast - Intellectia AI
agilon health inc (AGL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
agilon health inc (AGL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Top Agilon Health (AGL) Competitors 2026 - MarketBeat
agilon health inc (AGL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Agilon Health: agilon health, inc.Reverse Split Option Symbol: AGL New Symbol: AGL1 - Moomoo
Is ABCELLERA BIOLG (ABCL) Outperforming Other Medical Stocks This Year? - Yahoo Finance
agilon health inc (AGL) Institutional Confidence - TradingKey
agilon health inc (AGL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
When Will Agilon Health, Inc. (NYSE:AGL) Breakeven? - 富途牛牛
From senior care to primary care – how Agilon Health’s partnership model reshapes the AGL platfo - AD HOC NEWS
Agilon Health (AGL) Stock Forecast & Analyst Ratings - Moomoo
Agilon health stock hits 52-week high at 101.91 USD By Investing.com - Investing.com Australia
3 Russell 2000 Stocks We’re Skeptical Of - The Globe and Mail
agilon health to Participate in Upcoming Conferences - New Castle News
Agilon health stock hits 52-week high at 101.91 USD - Investing.com
agilon health inc stock (US00857U1079): shares among 2026’s high-flyers after massive year-to-date - AD HOC NEWS
Finanzdaten der Agilon Health Inc-Aktie (AGL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.58%
0.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):